Latest Strategy News

Energy Transition Minerals has submitted a binding offer to acquire the Penouta Mine in Spain, a critical asset for Europe’s supply of tantalum and niobium. The outcome hinges on regulatory approvals and competitive bidding.

King River Resources has reported significant gold assay results from its April 2025 drilling at Kurundi Main and promising geochemical anomalies at Kuiper, setting the stage for imminent drilling at these Northern Territory targets.

Macquarie Technology Group’s subsidiary has secured an option to acquire a prime Sydney site for a major new data centre campus, aiming to boost capacity for AI, cloud, and government clients.

DroneShield is investing $13 million to significantly expand its R&D and manufacturing footprint, aiming to boost annual production capacity nearly fivefold by the end of 2026.

Stellar Resources has extended its Memorandum of Understanding with Australian Hualong to explore using existing infrastructure near its Heemskirk Tin Project, aiming to enhance development plans and increase tin production.

Tungsten Mining NL is pivoting its Mt Mulgine Project development by targeting near-surface oxide gold to generate early cash flow and support its long-term tungsten ambitions. A 10-week integrated scoping study will soon assess this dual-resource approach.

Stavely Minerals has reported a significant high-grade gold intercept at its Fairview South prospect, extending mineralisation over a large strike length and setting the stage for expanded exploration.

Nordic Resources has expanded its gold inventory by 34%, adding 264,000 ounces from its newly updated Hirsikangas project in Finland, lifting total resources to 1.23 million ounces gold equivalent.

Tyranna Resources has agreed to acquire a 70% interest in the Maongo Copper-Gold Project in Angola, marking a strategic expansion into demand-driven metals with promising historical mining activity and strong infrastructure access.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Bio-Gene Technology Limited has announced an offer of over 95 million Placement Options to investors and its Lead Manager, contingent on shareholder approval at an upcoming extraordinary general meeting. If exercised, these options could inject approximately $3.8 million into the company.

Platinum Capital Limited has unveiled a proposed restructure via a scheme of arrangement, offering shareholders the option to exchange their shares for units in the Platinum International Fund Complex ETF (PIXX). The move aims to address the persistent discount to net tangible asset value (NTA) and improve liquidity.